aTyr Pharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell aTyr Pharma and other ETFs, options, and stocks.

About ATYR

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1.

CEO

Sanjay S. Shukla

CEOSanjay S. Shukla

Employees

Employees59

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2005

Founded2005

Employees

Employees59

ATYR Key Statistics

Market cap

334.21M

Market cap334.21M

Price-Earnings ratio

-4.65

Price-Earnings ratio-4.65

Dividend yield

—

Dividend yield—

Average volume

1.49M

Average volume1.49M

High today

$3.97

High today$3.97

Low today

$3.70

Low today$3.70

Open price

$3.78

Open price$3.78

Volume

991.98K

Volume991.98K

52 Week high

$4.66

52 Week high$4.66

52 Week low

$1.42

52 Week low$1.42

Analyst ratings

100%

of 11 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ATYR. This list is generated using Robinhood data, and it’s not a recommendation.

aTyr Pharma

Why Robinhood?

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. Show more

ATYR Key Statistics

Analyst ratings

100%

People also own

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1.